CommentaryGastric cancer epidemiology and risk factors
Introduction
The second half of the 20th century has seen a sharp worldwide decline in both the incidence and mortality of gastric cancer. Despite this, the condition remains the world's second leading cause of cancer mortality behind lung cancer. It has been estimated that there will have been more than 870,000 deaths from the disease in the year 2000, accounting for approximately 12% of all cancer deaths 1, 2, 3.
Gastric cancer has attracted much attention from epidemiologic investigators over recent years, particularly with the emergence of H. pylori as a risk factor for the condition. This has lead to an improved understanding of the etiology and pathogenesis of gastric cancer and raised the possibility of active prevention of the disease. Differences in exposures to H. pylori and a range of other environmental factors probably account for much of the variations seen in the incidence of gastric cancer over time and between populations.
We begin with a discussion of the pathology of gastric cancer, then consider descriptive epidemiology, and finally review the evidence concerning possible etiologic factors. The evidence described in this report was identified from the English language literature by searching the Medline database.
Section snippets
Pathology
Approximately 90% of stomach cancers are adenocarcinomas. Non-Hodgkin's lymphomas and leiomyosarcomas make up most of the remaining 10%.
Adenosquamous, squamous, and undifferentiated carcinomas also occur but are rare. Other very rare malignant primary tumors of the stomach include choriocarcinomas, carcinoid tumors, rhabdomyosarcomas, and hemangiopericytomas. Kaposi's sarcoma, in association with the acquired immunodeficiency syndrome, has also been reported [4].
Adenocarcinomas may be
Descriptive epidemiology
One of the notable features of the descriptive epidemiology concerning gastric cancer is that it establishes some clear distinctions between cancer localized to the gastric cardia and cancer of the rest of the stomach, as discussed below.
H. pylori
Since H. pylori was first reported by Marshall in 1983, a wealth of evidence has been gathered concerning this organism and its role in the etiology of gastric cancer [25]. In 1994, the International Agency for Research on Cancer classified H. pylori as carcinogenic to humans [26]. Evidence supporting a causal association between H. pylori and gastric cancer can be found in ecologic studies, case–control studies, and prospective cohort studies.
An international population study performed by the
Conclusions
Although much is known about the causes of gastric cancer, much still is shrouded in mystery. Particularly puzzling is the recent rise in adenocarcinoma around the cardia, largely confined to White males in affluent societies. One thing is clear. Contrary to a developing view that H. pylori is a major cause of gastric cancer, simple epidemiologic analysis shows that it is probably a minority cause in Western societies. If chronic H. pylori infection increases the risk of cancer by a factor of
Acknowledgments
The views presented in this article are those of the authors and are not intended to represent those of the Commonwealth Department of Veterans' Affairs or the Repatriation Medical Authority of the Commonwealth of Australia.
References (120)
- et al.
Comparative features of esophageal and gastric adenocarcinomas. Recent changes in type and frequency
Hum Pathol
(1986) - et al.
Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction
Gastroenterology
(1993) - et al.
Inverse association between intake of cereal fibre and risk of gastric cardia cancer
Gastroenterology
(2001) - et al.
Helicobacter pylori as a risk factor for cancer
Baillieres Clin Gastroenterol
(1995) - et al.
Helicobacter pylori infectionindependent risk indicator of gastric adenocarcinoma
Gastroenterology
(1993) - et al.
Helicobacter pylori and gastric cancer
Lancet
(1994) - et al.
Association of Helicobacter pylori infection with gastric carcinomaa meta-analysis
Am J Gastroenterol
(1999) - et al.
Long-term sequelae of Helicobacter pylori gastritis
Lancet
(1995) - et al.
Helicobacter pylori screening and gastric cancer (letter)
Lancet
(1996) - et al.
Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma
Lancet
(1991)
Regression of primary low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori
Lancet
Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection
Lancet
Helicobacter pylori reinfection and rapid relapse of low-grade B-cell gastric
Lancet
Incidence of second primary cancer following testicular cancer
Eur J Cancer
The decline of gastric cancerepidemiology of an unplanned triumph
Epidemiol Rev
Estimates of the worldwide incidence of eighteen major cancers in 1985
Int J Cancer
Estimates of worldwide mortality from eighteen major cancers in 1985. Implications for prevention, and projections of future burden
Int J Cancer
Tumours of the stomach
The two histological main types of gastric carcinomadiffuse and so-called intestinal-type carcinoma: an attempt at a histoloclinical classification
Acta Pathol Microbiol Scand
Cancer incidence in five continents, vol VII
Cancer incidence in five continents, vol VII
Histological types of gastric carcinoma in high and low risk areas
Int J Cancer
Decreased incidences of intestinal and diffuse types of gastric carcinoma in Finland during a 20-year period
Scand J Gastroenterol
Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States
J Natl Cancer Inst
The rising trend in oesophageal adenocarcinoma and gastric cardia
Eur J Cancer Prev
The time trend and age-period-cohort effects in incidence of adenocarcinoma of the stomach in Connecticut from 1955–1989
Cancer
Rising incidence of adenocarcinoma of the esophagus and gastric cardia
JAMA
Increasing incidence of both major histological types of esophageal carcinomas among men in Sweden
Int J Cancer
Rising Incidence of oesophageal adenocarcinoma in men in Australia
J Gastroenterol Hepatol
Adenocarcinoma of the esophagus in Switzerland
JAMA
Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma
N Engl J Med
Association between body mass and adenocarcinoma of the oesophagus and gastric cardia
Ann Intern Med
Body mass index and the risk of adenocarcinoma of the esophagus and gastric cardia
J Natl Cancer Inst
Unidentified curved bacilli on gastric epithelium in active chronic gastritis
Lancet
Schistosomes, liver flukes and Helicobacter pylori. IARC monographs on the evaluation of carcinogenic risks to humans, vol. 61
An international association between Helicobacter pylori infection and gastric cancer
Lancet
The cohort effect and Helicobacter pylori
J Infect Dis
Helicobacter pylori infection and chronic gastritis in gastric cancer
J Clin Pathol
Serum anti-Helicobacter pylori antibody and gastric carcinoma among young adults
Cancer
Possible role of Helicobacter pylori infection in early gastric cancer development
Cancer
Helicobacter pylori infection in a randomly selected population, healthy volunteers, and patients with gastric ulcer and gastric adenocarcinoma. A seroprevalence study in Taiwan
Scand J Gastroentol
Helicobacter pylori serology in patients with gastric carcinoma
Scand J Gastroenterol
Gastric adenocarcinoma and Helicobacter pylori infection
J Natl Cancer Inst.
Helicobacter pylori infection and the risk of gastric cancer
N Engl J Med
Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii
N Engl J Med
Association between infection with Helicobacter pylori and risk of gastric cancer; evidence of a prospective investigation
BMJ
Gastric cancer among the Japanese in Hawaii
Jpn J Cancer Res
Helicobacter pylori and gastric cancer; systematic review of epidemiological studies
Aliment Pharmacol Ther
Cited by (648)
Platycodin D induces apoptosis via regulating MAPK pathway and promotes autophagy in colon cancer cell
2024, Biomedicine and PharmacotherapyRisk prediction model of peritoneal seeding in advanced gastric cancer: A decision tool for diagnostic laparoscopy
2023, European Journal of Surgical OncologyFunctional mechanism and clinical implications of miR-141 in human cancers
2022, Cellular SignallingThe dual role of microRNA-9 in gastrointestinal cancers: oncomiR or tumor suppressor?
2022, Biomedicine and Pharmacotherapy